100 related articles for article (PubMed ID: 271428)
1. [A precise bioassay for in vivo mineralocorticoid activity in man: relation to plasma aldosterone in normal subjects, essential hypertension, hyperaldosteronism and adrenocortical insufficiency (author transl)].
Skrabal F
Wien Klin Wochenschr Suppl; 1977; 78():1-13. PubMed ID: 271428
[No Abstract] [Full Text] [Related]
2. [Low-renin hypertension and inherited mineralocorticoid diseases].
Kastelan D; Giljević Z; Perković Z; Plavsić V; Breskovac L; Aganović I; Korsić M
Lijec Vjesn; 1999; 121(7-8):245-9. PubMed ID: 10573960
[TBL] [Abstract][Full Text] [Related]
3. Steroid characteristics of mineralocorticoid adrenocortical hypertension.
Biglieri EG; Kater CE
Clin Chem; 1991 Oct; 37(10 Pt 2):1843-8. PubMed ID: 1914200
[TBL] [Abstract][Full Text] [Related]
4. An approach to mineralocorticoid hormone hypertension.
Biglieri EG
Cardiovasc Clin; 1978; 9(1):91-7. PubMed ID: 667888
[No Abstract] [Full Text] [Related]
5. [Mineralocorticoid function of the adrenal cortex under normal conditions and in pathology (review of the literature)].
Lebedev VP; Vodolazhskaia-Levina EE; Chemidze NP; Khovanskaia MP; Kalashnikova OA
Vopr Okhr Materin Det; 1971 Feb; 16(2):24-8. PubMed ID: 4933510
[No Abstract] [Full Text] [Related]
6. Subtraction potential difference: In-vivo assay for mineralocorticoid activity.
Skrabal F; Auböck J; Edwards CR; Braunsteiner H
Lancet; 1978 Feb; 1(8059):298-302. PubMed ID: 75336
[TBL] [Abstract][Full Text] [Related]
7. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
Skrabal F; Mauser R
Wien Klin Wochenschr; 1976 Dec; 88(23):777-81. PubMed ID: 1014711
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of a rapid test for the study of mineralocorticoid activity in the body].
Kiss R; Gláz E; Láng L; Rácz K; Varga I
Orv Hetil; 1983 Nov; 124(46):2789-92. PubMed ID: 6646743
[No Abstract] [Full Text] [Related]
9. Spectrum of mineralocorticoid hypertension.
Biglieri EG
Hypertension; 1991 Feb; 17(2):251-61. PubMed ID: 1846843
[No Abstract] [Full Text] [Related]
10. Aldosterone biosynthesis in the human adrenal cortex and associated disorders.
Nakamura Y; Yamazaki Y; Konosu-Fukaya S; Ise K; Satoh F; Sasano H
J Steroid Biochem Mol Biol; 2015 Sep; 153():57-62. PubMed ID: 26051166
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone and in vivo mineralocorticoid activity in normotensive and hypertensive man.
Skrabal F
J R Soc Med; 1979 Apr; 72(4):252-9. PubMed ID: 233248
[No Abstract] [Full Text] [Related]
12. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
[TBL] [Abstract][Full Text] [Related]
13. 10. Hypertension. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism.
Zoccali C; Usherwood T; Brown JJ; Lever AF; Robertson JI; Fraser R
J Steroid Biochem; 1983 Jul; 19(1A):327-31. PubMed ID: 6310234
[TBL] [Abstract][Full Text] [Related]
14. [Mineralocorticoid hypertension. A new form of secondary hypertension?].
Román O
Rev Med Chil; 1999 May; 127(5):511-3. PubMed ID: 10451619
[TBL] [Abstract][Full Text] [Related]
15. Arterial blood pressure and plasma and body electrolytes in idiopathic hyperaldosteronism: a comparison with primary hyperaldosteronism (Conn's syndrome) and essential hypertension.
Lasaridis A; Brown JJ; Davies DL; Fraser R; Robertson JI; Lever AF
J Hypertens; 1984 Aug; 2(4):329-36. PubMed ID: 6530544
[TBL] [Abstract][Full Text] [Related]
16. The role of adrenal mineralocorticoids in hypertension.
Tuck M
Geriatrics; 1978 Jan; 33(1):77-83. PubMed ID: 620928
[No Abstract] [Full Text] [Related]
17. [Determination of aldosterone and other mineralocorticoids].
Shimizu N; Yoshida H
Nihon Rinsho; 1976; 34 suppl():2132-46. PubMed ID: 792504
[No Abstract] [Full Text] [Related]
18. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism.
Willenberg HS; Kolentini C; Quinkler M; Cupisti K; Krausch M; Schott M; Scherbaum WA
Eur J Clin Invest; 2009 Jan; 39(1):43-50. PubMed ID: 19067735
[TBL] [Abstract][Full Text] [Related]
19. Disorders of the adrenal cortex: their effects on electrolyte metabolism.
Fraser R
Clin Endocrinol Metab; 1984 Jul; 13(2):413-30. PubMed ID: 6091953
[TBL] [Abstract][Full Text] [Related]
20. Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.
Kem DC; Weinberger MH; Gomez-Sanchez C; Kramer NJ; Lerman R; Furuyama S; Nugent CA
J Clin Invest; 1973 Sep; 52(9):2272-7. PubMed ID: 4353776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
